Gilead Sciences, Inc. (Nasdaq: NASDAQ:GILD) announced that the U.S. Food and Drug Administration (FDA) decided to remove its partial clinical hold on the company’s studies investigating magrolimab in combination with…
By Herbert Lash NEW YORK (Reuters) – Global stock markets fell on Monday, pulled lower by technology shares in Europe and on Wall Street, as U.S. Treasury yields jumped ahead…
By Eva Mathews and Krystal Hu (Reuters) -Private equity firm Thoma Bravo will acquire SailPoint Technologies for $6.12 billion, the cybersecurity firm said on Monday, in the latest deal that…
By Jonathan Stempel (Reuters) – Daily Journal Corp, the publishing and software company where Warren Buffett’s business partner Charlie Munger helps oversee investments and until recently was chairman, on Monday…
By Ross Kerber (Reuters) -New York pension officials on Monday said they will support shareholder resolutions filed at major banks seeking quick cuts to financing of new fossil fuel development,…
By Svea Herbst-Bayliss BOSTON (Reuters) -Activist investment firm Sachem Head on Monday cut its slate of director nominees at US Foods Holding (NYSE:USFD) Co to five from seven, backing away…
(Reuters) – Brazilian airline Gol SA said on Monday it expects to report a loss of 1.98 real per share in the first quarter of 2022 and a loss of…
By Oliver Gray Investing.com – Dow futures moved slightly higher in overnight trading on Monday, following declines among major benchmark averages during regular trade as U.S. Treasury yields surged ahead…
By Dietrich Knauth (Reuters) -Walgreens Boots Alliance Inc supplied billions of opioid pills to drug addicts and criminals, contributing to an addiction epidemic in Florida, a lawyer for the state…
By Stephen Culp NEW YORK (Reuters) – Wall Street closed sharply lower on Monday as investors started the holiday-shortened week in a risk-off mood, as rising bond yields weighed on…
